Acemetacin — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

1 Recruiting

1 Completed trials

3 Sponsors

2 Countries

Phase III

Phase IV

Phase III: 1 Phase IV: 1

Oversight events:

2 temporary halts 1 corrective measure across 1 trial

Indications tested

2 total

Direct comparison between NSAIDs and biosimilar TNFa blockers in patients with axial spondyloarthritis Recruiting

2024-513213-13-00 Phase IV 1 country St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr
Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain Ended

2022-502151-54-00 Phase III 2 countries Apurano Pharmaceuticals GmbH; Cannaxan GmbH

Showing 1–2 of 2 trials